[email protected]
CAS 79517-01-4 Octreotide molecular structure lightbox
CAS RN: 79517-01-4

Octreotide

Product Availability

Choose a grade to view its available package options.

11 package records10 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250128 10mg In stock Shanghai, Guangdong Inquiry
Batchno.20251225 250mg In stock Shanghai Inquiry
Batchno.20260429 50mg In stock Shanghai, Shandong Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250505 1ml Out of stock 8-10 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250318 100mg In stock Shanghai Inquiry
Batchno.20251121 10mg In stock Shanghai Inquiry
Batchno.20250804 1g In stock Shanghai Inquiry
Batchno.20260429 1mg In stock Shanghai Inquiry
Batchno.20250521 250mg In stock Shanghai Inquiry
Batchno.20260113 50mg In stock Shanghai, Shenzhen Inquiry
Batchno.20250621 5mg In stock Shanghai Inquiry
  • Product code: SSC-188659
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 79517-01-4
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥95% 0 Out of Stock Beijing Inquiry

79517-01-4 / acetic acid;10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

Standard CAS: 79517-01-4 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
79517-01-4
Multi CAS
Yes
Molecular Formula
C51H70N10O12S2
Molecular Weight
1079.300000
Exact Mass
1078.461610
InChI
InChI=1S/C49H66N10O10S2.2C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;2*1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);2*1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;;/m1../s1
InChIKey
QWFYIFWTVZFPRY-LODIGNQBSA-N

Computed Properties

Structural Parameters

Heavy atom count
75
Aromatic heavy atom count
21
Fraction Csp3
0.45
Rotatable bonds
17
H-bond acceptors
15
H-bond donors
14
Molar refractivity
285.36
TPSA
369.52

LogP / Solubility

WLOGP
-0.71
MLOGP
-0.52
XLogP3
-0.71
Consensus LogP
-0.65
Log S (ESOL)
-5.17
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.89
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.12
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-9.81

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Customers Also Viewed

Get In Touch

Contact Us